| Identification | Back Directory | [Name]
4-chloro-3-[[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methyl-1-oxobutyl]amino]-cyclopropyl-(S)-Benzenepropanoic acid | [CAS]
1402936-61-1 | [Synonyms]
Runcaciguat
inhibit,Runcaciguat,Inhibitor,Guanylate Cyclase
(R)-3-(4-chloro-3-((2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanamido)phenyl)-3-cyclopropylpropanoic acid
4-chloro-3-[[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methyl-1-oxobutyl]amino]-cyclopropyl-(S)-Benzenepropanoic acid
Benzenepropanoic acid, 4-chloro-3-[[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methyl-1-oxobutyl]amino]-β-cyclopropyl-, (βS)- | [EINECS(EC#)]
815-430-1 | [Molecular Formula]
C23H22Cl2F3NO3 | [MDL Number]
MFCD32062664 | [MOL File]
1402936-61-1.mol | [Molecular Weight]
488.33 |
| Chemical Properties | Back Directory | [Boiling point ]
600.5±55.0 °C(Predicted) | [density ]
1.416±0.06 g/cm3(Predicted) | [solubility ]
DMSO : 125 mg/mL (255.97 mM; Need ultrasonic) | [form ]
Solid | [pka]
4.56±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Runcaciguat is an orally active stimulator of soluble guanylate cyclase, and is used in the research of cardiovascular and renal diseases combined with selective partial adenosine A1 receptor agonists[1]. | [References]
[1] Barbara ALBRECHT-KüPPER, et al. Selective partial adenosine a1 receptor agonists in combination with soluble guanylyl cyclase (sgc) stimulators and/or activators. WO2018153899A1. |
|
|